查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1585837

溴病治疗市场：依治疗方法、依适应症分类 - 全球预测 2025-2030

Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年溴病治疗市场价值为4.4867亿美元，预计2024年将达到4.8903亿美元，复合年增长率为9.39%，2030年将达到8.4104亿美元。

狐臭，俗称狐臭，是由大汗腺和小汗腺分泌物细菌分解引起的。治疗范围包括局部和全身治疗、生活方式调整，以及晚期病例的手术介入。腋臭治疗的必要性因其显着的社会心理影响而凸显，影响人际关係和工作互动，刺激了对有效解决方案的需求。这些治疗的应用范围从非处方除臭剂到处方药再到先进的雷射和外科手术，最终用途包括医院、专科诊所和居家医疗。影响市场成长的主要因素包括个人卫生意识的提高、可支配收入的增加以及治疗方法的进步。潜在的治疗机会包括开发个人化治疗方法、使用生物技术开发新型治疗剂以及除臭剂配方中的天然和有机成分，以满足对环保产品日益增长的需求。然而，由于替代疗法的存在、某些药物相关的副作用以及可能抑制患者参与的文化偏见，该市场面临着限制。挑战还包括监管障碍以及与雷射和手术等先进治疗相关的高成本。生物技术的创新可能为针对特定细菌的新型抗生素铺平道路，并提高狐臭治疗的有效性。此外，探索微生物组研究和遗传倾向等领域可能会带来预防医学的突破。溴多汗症治疗市场竞争激烈，各公司不断努力创新，同时维持实惠的价格。为了实现业务成长，重点关註消费者教育、扩大我们的分销网络并促进与皮肤科医生和医疗保健提供者的合作非常重要。结合数位行销策略并提供个人化护理选项将进一步提高市场渗透率和消费者忠诚度。

主要市场统计
基准年[2023] 4.4867 亿美元
预测年份 [2024] 4.8903亿美元
预测年份 [2030] 84104万美元
复合年增长率（%） 9.39%

市场动态：快速发展的溴病治疗市场的关键市场洞察

供需的动态交互作用正在改变溴病治疗市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 溴多汗症、肾臟和肝臟疾病增加
    • 增加临床试验和研发活动的投资
    • 对体臭问题的认识
  • 市场限制因素
    • 治疗费用上涨
  • 市场机会
    • 治疗产品核准迅速增加
    • 以微波治疗腋窝多汗症和腋臭
  • 市场挑战
    • 产品召回及不良健康影响

波特五力：开拓溴病治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解溴病治疗市场的外部影响

外部宏观环境因素在塑造溴病治疗市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解溴病治疗市场的竞争状况

溴病治疗市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵溴病治疗市场供应商绩效评估

FPNV 定位矩阵是评估溴病治疗市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划溴病治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对溴病治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 狐臭、肾臟和肝臟疾病增加
      • 增加临床试验和研发活动的投资
      • 对体臭问题的认识
    • 抑制因素
      • 治疗费用高
    • 机会
      • 治疗产品的监管核准迅速增加
      • 微波治疗腋窝多汗、腋臭简介
    • 任务
      • 产品召回及不良健康影响
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 溴病治疗市场（依治疗）

  • 肉毒桿菌
  • 抽脂手术
  • 外科手术

第七章 溴病治疗市场（依适应症）

  • 红斑
  • 擦烂
  • 腋癣
  • 2型糖尿病

第八章北美和南美溴病治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区溴病治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲溴病治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Biovencer Healthcare Pvt. Ltd.
  • Boehringer Ingelheim International GmbH
  • Galderma SA
  • Hikma Pharmaceuticals PLC
  • Ipsen Biopharmaceuticals, Inc.
  • Johnson & Johnson
  • Journey Medical Corp.
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Novartis AG
  • Pfizer Inc.
Product Code: MRR-742BD517C23C

The Bromhidrosis Disease Treatment Market was valued at USD 448.67 million in 2023, expected to reach USD 489.03 million in 2024, and is projected to grow at a CAGR of 9.39%, to USD 841.04 million by 2030.

Bromhidrosis, commonly known as body odor, arises from bacterial decomposition of apocrine and eccrine gland secretions. The scope of treatment involves topical and systemic therapies, lifestyle adjustments, and in advanced cases, surgical intervention. The necessity of bromhidrosis treatments is underscored by its significant psychosocial impact, which can affect personal relationships and professional interactions, fueling demand for effective solutions. The applications of such treatments extend from over-the-counter deodorants to prescription medications and advanced laser or surgical procedures, with end-use ranging across hospitals, specialty clinics, and home care settings. Key factors influencing market growth include rising awareness about personal hygiene, increased disposable income, and advancements in medical treatments. Potential opportunities lie in the development of personalized treatment regimens, leveraging biotechnology for novel therapeutics, and the incorporation of natural and organic ingredients in deodorant formulations to cater to the growing demand for eco-friendly products. However, the market faces limitations due to the presence of alternative treatments, side effects associated with certain medications, and cultural stigmas that may hinder patient engagement. Challenges also include regulatory hurdles and the high costs associated with advanced treatments like lasers and surgeries. Innovations in biotechnology could pave the way for new antibiotics targeting specific bacteria, enhancing the efficacy of bromhidrosis treatments. Furthermore, exploring areas like microbiome research and genetic predisposition could lead to breakthroughs in preventive care. The nature of the bromhidrosis treatment market is highly competitive, with companies continuously striving to innovate while maintaining affordability. For business growth, focusing on consumer education, expanding distribution networks, and fostering collaboration with dermatologists and healthcare providers will be crucial. Embracing digital marketing strategies and offering personalized care options could further enhance market penetration and consumer loyalty.

KEY MARKET STATISTICS
Base Year [2023] USD 448.67 million
Estimated Year [2024] USD 489.03 million
Forecast Year [2030] USD 841.04 million
CAGR (%) 9.39%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bromhidrosis Disease Treatment Market

The Bromhidrosis Disease Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of bromhidrosis and kidney and liver diseases
    • Rising investments in the clinical trials and R&D activities
    • Awareness about body odor issues
  • Market Restraints
    • High cost of treatment
  • Market Opportunities
    • Rapid proliferation of regulatory approvals of treatment products
    • Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
  • Market Challenges
    • Product recalls and adverse health effects

Porter's Five Forces: A Strategic Tool for Navigating the Bromhidrosis Disease Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bromhidrosis Disease Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bromhidrosis Disease Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bromhidrosis Disease Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bromhidrosis Disease Treatment Market

A detailed market share analysis in the Bromhidrosis Disease Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bromhidrosis Disease Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bromhidrosis Disease Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bromhidrosis Disease Treatment Market

A strategic analysis of the Bromhidrosis Disease Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bromhidrosis Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma S.A., Hikma Pharmaceuticals PLC, Ipsen Biopharmaceuticals, Inc., Johnson & Johnson, Journey Medical Corp., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, and Pfizer Inc..

Market Segmentation & Coverage

This research report categorizes the Bromhidrosis Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Treatment, market is studied across Botox, Liposuction, and Surgery.
  • Based on Indication, market is studied across Erythrasma, Intertrigo, Trichomycosis Axillaries, and Type 2 Diabetes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of bromhidrosis and kidney and liver diseases
      • 5.1.1.2. Rising investments in the clinical trials and R&D activities
      • 5.1.1.3. Awareness about body odor issues
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid proliferation of regulatory approvals of treatment products
      • 5.1.3.2. Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
    • 5.1.4. Challenges
      • 5.1.4.1. Product recalls and adverse health effects
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Bromhidrosis Disease Treatment Market, by Treatment

  • 6.1. Introduction
  • 6.2. Botox
  • 6.3. Liposuction
  • 6.4. Surgery

7. Bromhidrosis Disease Treatment Market, by Indication

  • 7.1. Introduction
  • 7.2. Erythrasma
  • 7.3. Intertrigo
  • 7.4. Trichomycosis Axillaries
  • 7.5. Type 2 Diabetes

8. Americas Bromhidrosis Disease Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Bromhidrosis Disease Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Biovencer Healthcare Pvt. Ltd.
  • 3. Boehringer Ingelheim International GmbH
  • 4. Galderma S.A.
  • 5. Hikma Pharmaceuticals PLC
  • 6. Ipsen Biopharmaceuticals, Inc.
  • 7. Johnson & Johnson
  • 8. Journey Medical Corp.
  • 9. Medytox Inc.
  • 10. Merz Pharma GmbH and Co. KGaA
  • 11. Novartis AG
  • 12. Pfizer Inc.

LIST OF FIGURES

  • FIGURE 1. BROMHIDROSIS DISEASE TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BROMHIDROSIS DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BROMHIDROSIS DISEASE TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTOX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ERYTHRASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTERTRIGO, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TRICHOMYCOSIS AXILLARIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 102. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023